AU2002256260A1 - Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas - Google Patents

Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas

Info

Publication number
AU2002256260A1
AU2002256260A1 AU2002256260A AU2002256260A AU2002256260A1 AU 2002256260 A1 AU2002256260 A1 AU 2002256260A1 AU 2002256260 A AU2002256260 A AU 2002256260A AU 2002256260 A AU2002256260 A AU 2002256260A AU 2002256260 A1 AU2002256260 A1 AU 2002256260A1
Authority
AU
Australia
Prior art keywords
isoquinolyl
quinolyl
inhibition
raf kinase
pyridyl ureas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002256260A
Inventor
Jacques Dumas
David E. Gunn
Holia Hatoum-Mokdad
Uday Khire
Timothy B. Lowinger
Mary-Katherine Monahan
Bernd Riedl
William J. Scott
Robert N. Sibley
Roger A. Smith
Jill E. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of AU2002256260A1 publication Critical patent/AU2002256260A1/en
Abandoned legal-status Critical Current

Links

AU2002256260A 2001-04-20 2002-04-18 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas Abandoned AU2002256260A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/838,285 2001-04-20

Publications (1)

Publication Number Publication Date
AU2002256260A1 true AU2002256260A1 (en) 2002-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002238042A1 (en) Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
AU2002362895A1 (en) 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
WO2002085857A3 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
PL370163A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
HUP0400375A3 (en) Composition containing fat oil and onion extract, the production and use thereof
EP1381598A4 (en) Novel tyrosine kinase inhibitors
MXPA03006420A (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
IS6846A (en) Nicotinamide baryl derivatives useful for inhibiting PDE4 isotopic enzymes
CY2007002I1 (en) O-CARBOXYARYLIPOCUTATED BIFINYLUREAS AS RAF KINASE INHIBITORS
AU2002361577A1 (en) Tyrosine kinase inhibitors
AU2002360561A1 (en) 4-substituted piperidines, and methods of use thereof
MXPA03007848A (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same.
DK1480983T3 (en) Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl 6,7,8,9-tetrahydropyrimido [1,2a] pyrimidine-4-undivatives
AU2002348394A1 (en) Tyrosine kinase inhibitors
ATE303388T1 (en) SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDOC1,2-AÖPYRIMIDINE-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO-C1,2-AÖPYRIMIDINE-5(1H)ONE DERIVATIVES
AU2002348020A1 (en) Tyrosine kinase inhibitors
AU2002348393A1 (en) Tyrosine kinase inhibitors
AU2002323406A1 (en) Tyrosine kinase inhibitors
MXPA03001484A (en) Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof.
AU2002327534A1 (en) Tyrosine kinase inhibitors
AU2002358856A1 (en) Novel artemisinine derivatives, and uses thereof for treating malaria
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
AU2002256260A1 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors